We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

79 hedge funds and large institutions have $236M invested in Minerva Neurosciences in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

18% more capital invested

Capital invested by funds: $200M → $236M (+$35.9M)

0.07% more ownership

Funds ownership: 9.56% → 9.63% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 84 → 79 (-5)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
33
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
+$7.49M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$669K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$580K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$558K
5
Renaissance Technologies
Renaissance Technologies
New York
+$540K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.47M
2
HCMT
Highland Capital Management (Texas)
Texas
-$1.32M
3
Morgan Stanley
Morgan Stanley
New York
-$1.11M
4
SFM
Sphera Funds Management
Israel
-$1.05M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$931K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.06M +$12.7K +211 +1%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$1.04M +$360K +5,987 +57%
OAM
28
Oxford Asset Management
United Kingdom
$1.03M -$22.9K -381 -2%
Squarepoint
29
Squarepoint
New York
$1.01M +$221K +3,674 +30%
Citadel Advisors
30
Citadel Advisors
Florida
$869K +$135K +2,242 +19%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$860K +$137K +2,276 +20%
Goldman Sachs
32
Goldman Sachs
New York
$809K -$91.7K -1,526 -11%
AA
33
ALPS Advisors
Colorado
$738K +$30.5K +508 +5%
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$700K +$669K +11,138 New
BCM
35
Bridgeway Capital Management
Texas
$586K – – –
GCP
36
GSA Capital Partners
United Kingdom
$564K -$42.8K -712 -7%
TA
37
Teachers Advisors
New York
$549K +$6.61K +110 +1%
Charles Schwab
38
Charles Schwab
California
$539K +$21.6K +360 +4%
AWCI
39
Alpine Woods Capital Investors
New York
$474K – – –
Swiss National Bank
40
Swiss National Bank
Switzerland
$473K +$21K +350 +5%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$450K +$42.5K +707 +11%
Wells Fargo
42
Wells Fargo
California
$407K -$5.59K -93 -1%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$377K – – –
AllianceBernstein
44
AllianceBernstein
Tennessee
$375K +$12K +200 +3%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$325K +$70.6K +1,175 +29%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$315K -$6.67K -111 -2%
DCM
47
DAFNA Capital Management
California
$284K +$75.1K +1,250 +38%
Deutsche Bank
48
Deutsche Bank
Germany
$278K -$122K -2,026 -31%
Acadian Asset Management
49
Acadian Asset Management
Massachusetts
$261K -$324K -5,385 -57%
UBS AM
50
UBS AM
Illinois
$208K – – –
1
2
3 4

NERV Hedge Fund Activity: Q1 2019 in Review

79 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2019, worth a combined $236M — up 18% from $200M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NERV and 4 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 33 added.

The largest buyer was GMT Capital, opening a new position worth an estimated $7.49M. The largest seller was Millennium Management, cutting an estimated $2.47M.

  • 79 institutional investors held Minerva Neurosciences (NERV) as of Q1 2019, down from 84 in Q4 2018.
  • Funds reported $236M of Minerva Neurosciences stock for Q1 2019, up 18% quarter-over-quarter.
  • 4 funds opened new Minerva Neurosciences positions in Q1 2019 and 9 closed out, a net change of -5 holders.
  • The largest Minerva Neurosciences buyer in Q1 2019 was GMT Capital, an estimated $7.49M added.
  • The largest Minerva Neurosciences seller in Q1 2019 was Millennium Management, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2019.